drugdeliverybusiness2h
Senseonics to consider reverse stock split, reports strong Eversense 365 interest
Senseonics (NYSE:SENS) announced preliminary financial results for 2024 as it considers a reverse stock split.
drugdeliverybusiness22h
Hedia, Glooko launch personalized bolus insulin dosing tech
Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.